Is Lorazepam (Ativan) contraindicated in sinus bradycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Lorazepam (Ativan) is not absolutely contraindicated in sinus bradycardia, but caution is warranted due to its potential to worsen bradycardia in susceptible individuals. While Ativan primarily affects the central nervous system as a benzodiazepine, it can occasionally worsen bradycardia in susceptible individuals, as noted in clinical perspectives where bradycardia induced or exacerbated by concomitant drugs affecting sinus node function should be considered for drug discontinuation or dose reduction 1. Patients with pre-existing sinus bradycardia should be monitored carefully when receiving Ativan, especially when administered intravenously or at higher doses.

The medication works by enhancing the effect of GABA, an inhibitory neurotransmitter, which can indirectly affect heart rate through central mechanisms. If Ativan must be used in a patient with bradycardia, starting with a lower dose (such as 0.5 mg instead of 1-2 mg) and monitoring vital signs is advisable, considering the potential for physiological bradycardia due to autonomic conditions or training effects, as seen in trained athletes with sinus bradycardia (SB) as low as 40–50 bpm while at rest or as slow as 30 bpm while sleeping 1.

Key considerations include:

  • Monitoring patients with pre-existing sinus bradycardia carefully when receiving Ativan
  • Starting with a lower dose and monitoring vital signs
  • Being cautious in elderly patients or those taking other medications that can slow heart rate, such as beta-blockers or certain calcium channel blockers
  • Carefully considering the risk-benefit ratio, especially in severe bradycardia (heart rate below 50 beats per minute), and weighing the potential benefits of Ativan against the potential risks of exacerbating bradycardia.

From the Research

Lorazepam (Ativan) and Sinus Bradycardia

  • There is no direct evidence in the provided studies that suggests Lorazepam (Ativan) is contraindicated in sinus bradycardia 2, 3, 4, 5, 6.
  • The studies focus on the treatment and management of sinus bradycardia, sinus node dysfunction, and bradycardia, but do not mention Lorazepam (Ativan) as a contraindicated medication in these conditions.
  • However, it is worth noting that some medications can exacerbate bradycardia, and caution should be exercised when administering any medication that may affect heart rate 3, 5.

Mechanisms and Treatments

  • Sinus node dysfunction can be caused by intrinsic or extrinsic factors, and treatment typically involves addressing the underlying cause and managing symptoms 3.
  • Bradycardia can be a normal phenomenon in certain individuals, but it can also be a sign of underlying pathology, and treatment should be guided by a thorough evaluation of the patient's symptoms and medical history 5.
  • The use of pacemakers and other devices may be necessary in some cases to manage bradycardia and prevent complications 3, 4.

Heart Rate and Autonomic Function

  • Changes in heart rate can be influenced by various factors, including autonomic nervous function and the use of certain medications 6.
  • The relationship between heart rate and autonomic function is complex, and further research is needed to fully understand the mechanisms involved 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Sinus Node Dysfunction.

American family physician, 2021

Research

Development of heart failure in bradycardic sick sinus syndrome.

Italian heart journal : official journal of the Italian Federation of Cardiology, 2001

Research

Evaluating and managing bradycardia.

Trends in cardiovascular medicine, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.